Article
Experience of chromosomal microarray applied in prenatal and postnatal settings in Hong Kong
23 Mar 2019
Abstract excerpt
Chromosomal microarray (CMA) is recommended as a first tier investigation for patients with developmental delay (DD), intellectual disability (ID), autistic spectrum disorder (ASD), and multiple congenital anomalies (MCA). It is widely used in the prenatal and postnatal settings for detection of chromosomal aberrations. This is a retrospective review of all array comparative genomic hybridization (aCGH/ array...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
